Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02021630 · ClinicalTrials.gov registry record
The Collateral Impact of Bariatric Surgery on Families
A clinical trial of Obesity and Weight Loss, sponsored by Geisinger Clinic.
- Completed
- Registry status
- 97
- Enrollment target
- 1
- Study location
NCT02021630 is a study of Obesity and Weight Loss that has completed, run by Geisinger Clinic. The registered enrollment target is 97 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02021630, a study of Obesity and Weight Loss, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal is designed to examine the impact of bariatric surgery on the health of patients and their families. The shared environment of spouses/cohabitating partners suggests that patients' families are exposed to the extensive diet and lifestyle changes required of patients following bariatric surgery.
Conditions Studied
Interventions
- OTHER Outcomes
Study Locations (1)
Pennsylvania
- Geisinger Clinic - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02021630
The ClinicalTrials.gov registry entry for NCT02021630 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Outcomes is the first listed.
NCT02021630 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02021630 about?
NCT02021630 is a clinical study titled "The Collateral Impact of Bariatric Surgery on Families". This proposal is designed to examine the impact of bariatric surgery on the health of patients and their families. The shared environment of spouses/cohabitating partners suggests that patients' families are exposed to the extensive diet and lifestyle changes required of patients following bariatric...
What is the current status of trial NCT02021630?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2012-12. Estimated completion is 2016-07.
What conditions does trial NCT02021630 study?
This clinical trial studies the following conditions: Obesity, Weight Loss, Bariatric Surgery Candidate.
What interventions are being tested in trial NCT02021630?
The interventions under investigation include: Outcomes (OTHER).
Who is sponsoring clinical trial NCT02021630?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02021630 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.